Rifaximin and pharmaceutical compositions containing it in...

Details Rifaximin and pharmaceutical compositions containing it in... Rifaximin and pharmaceutical compositions containing it in...

A - Human Necessities

61

K

A61K 31/44 (2006.01)

Patent

CA 2115381

This invention refers to the use of the rifamycin antibiotic known by the name of rifaximin (INN) and to pharmaceutical compositions containing it in the oral treatment of the forms of gastric dyspepsia caused by bacteria known as Helicobacter pylori. Rifaximin may be administered in any oral pharmaceutical form, particularly tablets, capsules, sugar coated tablets, granules and syrups containing from 200 to 2000 mg of active principle, at a daily dosage of between 400 and 2000 mg.

Affiliated with

Also associated with

Rating

Rifaximin and pharmaceutical compositions containing it in... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Rifaximin and pharmaceutical compositions containing it in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Rifaximin and pharmaceutical compositions containing it in... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1911995